Figure 3
Figure 3. Splenic ferroportin expression and splenic iron concentration in WT, Hfe−/−, Tfr2−/−, and Hfe−/−/Tfr2−/− mice treated with LPS. (A) Western blotting was used to determine the expression of ferroportin in the spleens of 5-week-old male WT, Hfe−/−, Tfr2−/−, and Hfe−/−/Tfr2−/− mice injected with saline or LPS for 6 hours. The blots in panel A were quantitated and results are shown relative to Gapdh for saline-injected (white bars) and LPS-injected (black bars) mice (B). Splenic iron concentration was determined in all mice (C). Data are shown as the means; error bars indicate SEM. Statistical comparisons were performed using the Student t test. Significant differences (P < .05) are denoted between control and LPS treatments (*) and between strains compared with WT (a), with Hfe−/− (b), and with Tfr2−/− (c).

Splenic ferroportin expression and splenic iron concentration in WT, Hfe−/−, Tfr2−/−, and Hfe−/−/Tfr2−/− mice treated with LPS. (A) Western blotting was used to determine the expression of ferroportin in the spleens of 5-week-old male WT, Hfe−/−, Tfr2−/−, and Hfe−/−/Tfr2−/− mice injected with saline or LPS for 6 hours. The blots in panel A were quantitated and results are shown relative to Gapdh for saline-injected (white bars) and LPS-injected (black bars) mice (B). Splenic iron concentration was determined in all mice (C). Data are shown as the means; error bars indicate SEM. Statistical comparisons were performed using the Student t test. Significant differences (P < .05) are denoted between control and LPS treatments (*) and between strains compared with WT (a), with Hfe−/− (b), and with Tfr2−/− (c).

Close Modal

or Create an Account

Close Modal
Close Modal